Anti-inflammatory effects of Rubus coreanus Miquel through inhibition of NF-κB and MAP Kinase
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Rubus Coreanus Miquel (RCM), used as a traditional Korean medicine, reduces chronic inflammatory diseases such as cancer and rheumatoid arthritis. However, its mechanism has not been elucidated. In this study, we examine the anti-inflammatory effects of RCM and their possible mechanisms using RAW 264.7 cells. MATERIALS/METHODS: Unripe RCM ethanol extract (UE), unripe RCM water extract (UH), ripe RCM ethanol extract (RE), and ripe RCM water extract (RH) were prepared. Inflammatory response was induced with LPS treatment, and expression of pro-inflammatory mediators (iNOS, COX-2, TNF-α, IL-1β, and IL-6) and NO and PGE2 productions were assessed. To determine the anti-inflammatory mechanism of RCM, we measured NF-κB and MAPK activities. RESULTS: UE and UH treatment significantly reduced NF-κB activation and JNK and p38 phosphorylation and reduced transcriptional activities decreased iNOS, COX-2, and pro-inflammatory cytokines expressions, and NO and PGE2 productions. RE and RH treatments reduced IL-1β and IL-6 expressions through suppressions of JNK and p38 phosphorylation. CONCLUSIONS: In this study, we showed that RCM had anti-inflammatory effects by suppression of pro-inflammatory mediator expressions. Especially, unripe RCM showed strong anti-inflammatory effects through suppression of NF-κB and MAPK activation. These findings suggest that unripe RCM might be used as a potential functional material to reduce chronic inflammatory responses.
Abstract
BACKGROUND/OBJECTIVES: Rubus Coreanus Miquel (RCM), used as a traditional Korean medicine, reduces chronic inflammatory diseases such as cancer and rheumatoid arthritis. However, its mechanism has not been elucidated. In this study, we examine the anti-inflammatory effects of RCM and their possible mechanisms using RAW 264.7 cells. MATERIALS/METHODS: Unripe RCM ethanol extract (UE), unripe RCM water extract (UH), ripe RCM ethanol extract (RE), and ripe RCM water extract (RH) were prepared. Inflammatory response was induced with LPS treatment, and expression of pro-inflammatory mediators (iNOS, COX-2, TNF-α, IL-1β, and IL-6) and NO and PGE2 productions were assessed. To determine the anti-inflammatory mechanism of RCM, we measured NF-κB and MAPK activities. RESULTS: UE and UH treatment significantly reduced NF-κB activation and JNK and p38 phosphorylation and reduced transcriptional activities decreased iNOS, COX-2, and pro-inflammatory cytokines expressions, and NO and PGE2 productions. RE and RH treatments reduced IL-1β and IL-6 expressions through suppressions of JNK and p38 phosphorylation. CONCLUSIONS: In this study, we showed that RCM had anti-inflammatory effects by suppression of pro-inflammatory mediator expressions. Especially, unripe RCM showed strong anti-inflammatory effects through suppression of NF-κB and MAPK activation. These findings suggest that unripe RCM might be used as a potential functional material to reduce chronic inflammatory responses.
참고문헌 (47)
- Laroux FS, "Mechanisms of inflammation: the good, the bad and the ugly", Front Biosci, 9, pp.3156~3162 (2004)
- Barnes PJ, "Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases", N Engl J Med, 336, pp.1066~1071 (1997)
- Blackwell TS, "The role of nuclear factor-kappa B in cytokine gene regulation", Am J Respir Cell Mol Biol, 17, pp.3~9 (1997)
- Ben-Neriah Y, "Inflammation meets cancer, with NF-kappaB as the matchmaker", Nat Immunol, 12, pp.715~723 (2011)
- Schmidt MI, "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study", Lancet, 353, pp.1649~1652 (1999)
- Pearson TA, "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107, pp.499~511 (2003)
- Tak PP, "NF-kappaB: a key role in inflammatory diseases", J Clin Invest, 107, pp.7~11 (2001)
- Lee JI, "Nuclear factor kappa B: important transcription factor and therapeutic target", J Clin Pharmacol, 38, pp.981~993 (1998)
- Brockman JA, "Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation", Mol Cell Biol, 15, pp.2809~2818 (1995)
- Siebenlist U, "Structure, regulation and function of NF-kappa B", Annu Rev Cell Biol, 10, pp.405~455 (1994)
- Chen C, "Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages", Immunology, 97, pp.124~129 (1999)
- Guha M, "LPS induction of gene expression in human monocytes", Cell Signal, 13, pp.85~94 (2001)
- Kim EJ, "Induction of apoptosis by the aqueous extract of Rubus coreanum in HT-29 human colon cancer cells", NUTRITION, 21, pp.1141~1148 (2005), ELSEVIER SCIENCE INC
- 라정찬, "복분자 함유 생약추출물의 체중 조절 효과에 관한 연구", 한국독성학회지, 20(2), pp.167~172 (2004), 한국독성학회
- Yang HM, "Antiinflammatory activities of Rubus coreanus depend on the degree of fruit ripening", PHYTOTHERAPY RESEARCH, 22, pp.102~107 (2008), JOHN WILEY & SONS LTD
- 김진경, "토종 복분자와 외래종 복분자 추출물의 항염증효과 비교", 한국식품과학회지, 39(3), pp.342~347 (2007), 한국식품과학회
- Kim Y, "Chemopreventive effects of Rubus coreanus Miquel on prostate cancer", Biosci Biotechnol Biochem, 76, pp.737~744 (2012)
- Kim YH, "23-Hydroxytormentic acid and nigaichgoside f(1) isolated from Rubus coreanus attenuate cisplatininduced cytotoxicity by reducing oxidative stress in renal epithelial LLC-PK(1) cells", Biol Pharm Bull, 34, pp.906~911 (2011)
- Lee J, "Rubus fruit phenolic research: the good, the bad, and the confusing", Food Chem, 130, pp.785~796 (2012)
- Pang KC, "Hydrolyzable tannins from the fruits of Rubus coreanum", Korean J Pharmacogn, 27, pp.366~370 (1996)
- Kim HS, "Biochemical monitoring of black raspberry (Rubus coreanus Miquel) fruits according to maturation stage by 1H-NMR using multiple solvent systems", Food Res Int, 44, pp.1977~1988 (2011)
- Ellis CL, "Attenuation of meal-induced inflammatory and thrombotic responses in overweight men and women after 6-week daily strawberry (Fragaria) intake. A randomized placebo-controlled trial", J Atheroscler Thromb, 18, pp.318~327 (2011)
- Terra X, "Grapeseed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet", J Nutr Biochem, 20, pp.210~218 (2009)
- E.M. Seymour, "Regular Tart Cherry Intake Alters Abdominal Adiposity, Adipose Gene Transcription, and Inflammation in Obesity-Prone Rats Fed a High Fat Diet", Journal of Medicinal Food, 12(5), pp.935~942 (2009), 한국식품영양과학회
- Kim HH, "Ripe fruit of Rubus coreanus inhibits mast cell-mediated allergic inflammation", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 29, pp.303~310 (2012), PROFESSOR D A SPANDIDOS
- Sangiovanni E, "Ellagitannins from Rubus berries for the control of gastric inflammation: in vitro and in vivo studies", PLoS One, 8, pp.e71762~ (2013)
- Lin Q, "Differentiation arrest by hypoxia", J Biol Chem, 281, pp.30678~30683 (2006)
- 김지명, "숙성에 따른 토종 복분자 딸기의 특성", 한국식품과학회지, 43(3), pp.341~347 (2011), 한국식품과학회
- Wang SY, "Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage", J Agric Food Chem, 48, pp.140~146 (2000)
- González R, "Effects of flavonoids and other polyphenols on inflammation", Crit Rev Food Sci Nutr, 51, pp.331~362 (2011)
- Herlaar E, "p38 MAPK signalling cascades in inflammatory disease", Mol Med Today, 5, pp.439~447 (1999)
- Fujioka S, "NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity", Mol Cell Biol, 24, pp.7806~7819 (2004)
- Whitmarsh AJ, "Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways", J Mol Med (Berl), 74, pp.589~607 (1996)
- Korhonen R, "Nitric oxide production and signaling in inflammation", Curr Drug Targets Inflamm Allergy, 4, pp.471~479 (2005)
- Nussler AK, "Inflammation, immunoregulation, and inducible nitric oxide synthase", J Leukoc Biol, 54, pp.171~178 (1993)
- Kleinert H, "Regulation of the expression of inducible nitric oxide synthase", Eur J Pharmacol, 500, pp.255~266 (2004)
- MacMicking J, "Nitric oxide and macrophage function", Annu Rev Immunol, 15, pp.323~350 (1997)
- Murakami A, "Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals", Int J Cancer, 121, pp.2357~2363 (2007)
- Dubois RN, "Cyclooxygenase in biology and disease", FASEB J, 12, pp.1063~1073 (1998)
- Lin CC, "Induction of COX-2", PGE(2), Free Radic Biol Med, pp.2010, 48[DOI]
- Willoughby DA, "COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease", Lancet, 355, pp.646~648 (2000)
- Tao JY, "Anti-inflammatory effects of ethyl acetate fraction from Melilotus suaveolens Ledeb on LPS-stimulated RAW 264.7 cells", J Ethnopharmacol, 123, pp.97~105 (2009)
- Feghali CA, "Cytokines in acute and chronic inflammation", Front Biosci, 2, pp.d12~d26 (1997)
- Weber CK, "Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta", Gastroenterology, 119, pp.1209~1218 (2000)
- Schäcke H, "Mechanisms involved in the side effects of glucocorticoids", Pharmacol Ther, 96, pp.23~43 (2002)
- Rogler G, "Gastrointestinal and liver adverse effects of drugs used for treating IBD", Best Pract Res Clin Gastroenterol, 24, pp.157~165 (2010)
- Schubert SY, "A novel mechanism for the inhibition of NF-κB activation in vascular endothelial cells by natural antioxidants", FASEB J, 16, pp.1931~1933 (2002)
